RS
VRTX icon

Rakuten Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Rakuten Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.93K Sell
20
-1
-5% -$466 ﹤0.01% 442
2025
Q4 		$9.52K Buy
21
+2
+11% +$862 ﹤0.01% 438
2025
Q3 		$7.44K Buy
19
+1
+6% +$418 ﹤0.01% 458
2025
Q2 		$8.01K Buy
18
+13
+260% +$5.99K ﹤0.01% 435
2025
Q1 		$2.42K Sell
5
-110
-96% -$51.3K ﹤0.01% 574
2024
Q4 		$46.3K Buy
115
+74
+180% +$34.3K 0.02% 211
2024
Q3 		$19.1K Buy
41
+20
+95% +$9.61K 0.01% 269
2024
Q2 		$9.84K Buy
21
+5
+31% +$2.17K ﹤0.01% 330
2024
Q1 		$6.69K Sell
16
-408
-96% -$172K ﹤0.01% 372
2023
Q4 		$173K Buy
+424
New +$157K 0.14% 95

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rakuten Securities's VRTX Position: Q1 2026 in Review

Rakuten Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 4.8% in Q1 2026, selling an estimated $466 and leaving 20 shares worth $8.93K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Rakuten Securities first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $173K in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Rakuten Securities held 20 shares of Vertex Pharmaceuticals worth $8.93K as of Q1 2026.
  • Rakuten Securities sold 1 Vertex Pharmaceuticals share in Q1 2026, an estimated $466.
  • Vertex Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q1 2026, its #442 holding.
  • Rakuten Securities first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's Vertex Pharmaceuticals position peaked at $173K in Q4 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.